Table 3.

Comparison of patient dose calculated by Mobius to AcurosXB for pre‐clinical test cases

Plan number	Target mean dose percent difference (%)	Target D95% percent difference (%)	3D global gamma pass rate (%)	Target gamma pass rate (%)
1	1.4a	−0.4a	94.4b	79.4b
2	1.7	0.6	98.5	95.3
3	2.6	2.4	94.4	62.2
4	1.3	−1.3	99.9	98.0
5	1.5	−0.2	94.0	75.7
6	1.1	−0.5	95.2	83.0
7	1.8	0.1	95.7	69.4
8	1.8	−0.1	97.3	69.4
9	2.1	0.1	96.3	64.7
10	2.5	1.1	92.0	58.5
11	−0.6	−2.8	97.4	92.9
12	−1.2	−4.4	87.9	80.7
13	0.6	−3.7	89.9	82.1
14	−0.6	−3.2	88.7	87.7
15	0.2	−0.8	96.1	98.6
16	−0.4	−3.9	92.9	79.9
17	1.6	1.2	94.3	85.4

^aA positive percent difference indicates that Mobius calculated dose is higher than AcurosXB.

^b3D global gamma pass rate and target gamma pass rate use gamma criteria of 3%, 2  mm.